Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-25

Clinical Trial Update: Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity. [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial examines whether tailoring immunosuppressive therapy for kidney transplant recipients based on pre-transplant donor-specific T-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Josep M Grinyo | Conditions: Disorder Related to Renal Transplantation | Phase 4 | Status: COMPLETED